{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:59:52Z","timestamp":1792648792001,"version":"4.5.0"},"reference-count":141,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2014,12,25]],"date-time":"2014-12-25T00:00:00Z","timestamp":1419465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Catheter-related bloodstream infection (C-RBSI) is one of the most frequent nosocomial infections. It is associated with high rates of morbidity and mortality. Candida spp. is the third most common cause of C-RBSI after coagulase-negative staphylococci and Staphylococcus aureus and is responsible for approximately 8% of episodes. The main cause of catheter-related candidemia is the ability of some Candida strains\u2014mainly C. albicans and C. parapsilosis\u2014to produce biofilms. Many in vitro and in vivo models have been designed to assess the activity of antifungal drugs against Candida biofilms. Echinocandins have proven to be the most active antifungal drugs. Potential options in situations where the catheter cannot be removed include the combination of systemic and lock antifungal therapy. However, well-designed and -executed clinical trials must be performed before firm recommendations can be issued.<\/jats:p>","DOI":"10.3390\/antibiotics4010001","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T05:52:39Z","timestamp":1419573159000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Role of Antifungals against Candida Biofilm in  Catheter-Related Candidemia"],"prefix":"10.3390","volume":"4","author":[{"given":"Emilio","family":"Bouza","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Gregorio Mara\u00f1\u00f3n Hospital,  Madrid 28007, Spain"},{"name":"Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain"},{"name":"CIBER de Enfermedades Respiratorias (CIBER RES), CB06\/06\/0058, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Guinea","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Gregorio Mara\u00f1\u00f3n Hospital,  Madrid 28007, Spain"},{"name":"Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Guembe","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Gregorio Mara\u00f1\u00f3n Hospital,  Madrid 28007, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100960050001","article-title":"Intravascular catheter-associated infections","volume":"19","author":"Crump","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhin.2005.02.009","article-title":"Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality","volume":"61","author":"Weinberger","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10096-008-0546-y","article-title":"A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia","volume":"27","author":"Velasco","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11046-013-9638-z","article-title":"Candida albicans and non-C. albicans Candida species: Comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections","volume":"175","author":"Ferreira","year":"2012","journal-title":"Mycopathologia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/CMR.6.2.176","article-title":"Pathogenesis of infections related to intravascular catheterization","volume":"6","author":"Goldmann","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/322972","article-title":"Biofilm formation: A clinically relevant microbiological process","volume":"33","author":"Donlan","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1369-5274(02)00371-5","article-title":"Candida biofilms","volume":"5","author":"Kumamoto","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: An update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tim.2011.02.003","article-title":"Adherence and biofilm formation of non-Candida albicans Candida species","volume":"19","author":"Silva","year":"2011","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/13693780802549594","article-title":"Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition","volume":"47","author":"Silva","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijmm.2014.08.012","article-title":"Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: Comparison of biomass production and metabolic activity and development of cut-off points","volume":"304","author":"Escribano","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tim.2009.08.007","article-title":"Can filamentous fungi form biofilms?","volume":"17","author":"Harding","year":"2009","journal-title":"Trends Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s15010-013-0455-6","article-title":"A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade","volume":"41","author":"Tortorano","year":"2013","journal-title":"Infection"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archinte.1988.00380120094019","article-title":"Hospital-acquired candidemia. The attributable mortality and excess length of stay","volume":"148","author":"Wey","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1128\/JCM.00214-08","article-title":"Time to blood culture positivity as a marker for catheter-related candidemia","volume":"46","author":"Weinberger","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/mmy\/myu013","article-title":"Is it feasible to diagnose catheter-related candidemia without catheter withdrawal?","volume":"52","author":"Perez","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1111\/1469-0691.12096","article-title":"Can microbiologists help to assess catheter involvement in candidaemic patients before removal?","volume":"19","author":"Bouza","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: Survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3201\/eid0702.010226","article-title":"Biofilms and device-associated infections","volume":"7","author":"Donlan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-407673-0.00002-3","article-title":"The clinical importance of fungal biofilms","volume":"84","author":"Ramage","year":"2013","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10408410903241436","article-title":"Our current understanding of fungal biofilms","volume":"35","author":"Ramage","year":"2009","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_22","first-page":"163","article-title":"Characteristics of biofilm formation by Candida albicans","volume":"18","author":"Ramage","year":"2001","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.mib.2006.06.007","article-title":"Candida albicans biofilm development, modeling a host-pathogen interaction","volume":"9","author":"Nett","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.mib.2006.10.003","article-title":"How to build a biofilm: A fungal perspective","volume":"9","author":"Blankenship","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1099\/00222615-48-7-671","article-title":"Role of dimorphism in the development of Candida albicans biofilms","volume":"48","author":"Baillie","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/AEM.67.7.2982-2992.2001","article-title":"Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol","volume":"67","author":"Hornby","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e17632","DOI":"10.1371\/journal.pone.0017632","article-title":"A role for amyloid in cell aggregation and biofilm formation","volume":"6","author":"Garcia","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-60761-971-0_16","article-title":"Linking quorum sensing regulation and biofilm formation by Candida albicans","volume":"692","author":"Deveau","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1002585","DOI":"10.1371\/journal.ppat.1002585","article-title":"Fungal biofilms","volume":"8","author":"Fanning","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J. Bacteriol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/EC.05126-11","article-title":"Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation","volume":"10","author":"Nett","year":"2011","journal-title":"Eukaryot Cell."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mimet.2010.08.018","article-title":"In vitro and in vivo model systems to study microbial biofilm formation","volume":"83","author":"Coenye","year":"2010","journal-title":"J. Microbiol. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/iai.62.3.915-921.1994","article-title":"Biofilm formation by Candida species on the surface of catheter materials in vitro","volume":"62","author":"Hawser","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4161\/viru.1.6.13186","article-title":"An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow","volume":"1","author":"Uppuluri","year":"2010","journal-title":"Virulence"},{"key":"ref_35","unstructured":"Lebeaux, D.K.I., Decante, B., Ghigo, J., Beloin, C., and Plessis-Robinson, L. (2011, January 7\u201310). Modelling of controlled biofilm infection using rats with totally implantable port access intravenous catheter. Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy. Abstract No. O187."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/978-1-61779-539-8_40","article-title":"Modeling of fungal biofilms using a rat central vein catheter","volume":"845","author":"Nett","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4161\/viru.2.5.16341","article-title":"A rabbit model for evaluation of catheter-associated fungal biofilms","volume":"2","author":"Chandra","year":"2011","journal-title":"Virulence"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1099\/mic.0.033530-0","article-title":"Candida albicans biofilm formation in a new in vivo rat model","volume":"156","author":"Ricicova","year":"2010","journal-title":"Microbiology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"O\u2019Toole, G.A. (2011). Microtiter dish biofilm formation assay. J. Vis. Exp.","DOI":"10.3791\/2437-v"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1472-765X.2004.01513.x","article-title":"Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface","volume":"38","author":"Stepanovic","year":"2004","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/13693786.2011.580016","article-title":"Comparative analysis of Candida biofilm quantitation assays","volume":"50","author":"Taff","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.41.1.506-508.2003","article-title":"Uses and limitations of the XTT assay in studies of Candida growth and metabolism","volume":"41","author":"Kuhn","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/JCM.36.5.1450-1452.1998","article-title":"Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents","volume":"36","author":"Hawser","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/152.5.938","article-title":"A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT","volume":"152","author":"Levitz","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13693780500338084","article-title":"Biofilm production by clinical isolates of Candida species","volume":"44","author":"Kumar","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/mmy\/myt031","article-title":"Is biofilm production a predictor of catheter-related candidemia?","volume":"52","author":"Guembe","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11046-013-9616-5","article-title":"Candidemia by species of the Candida parapsilosis complex in children\u2019s hospital: Prevalence, biofilm production and antifungal susceptibility","volume":"175","author":"Ruiz","year":"2013","journal-title":"Mycopathologia"},{"key":"ref_50","first-page":"139","article-title":"Medical importance of biofilms in Candida infections","volume":"19","author":"Douglas","year":"2002","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","article-title":"Candida infections of medical devices","volume":"17","author":"Kojic","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","article-title":"Candida biofilms on implanted biomaterials: A clinically significant problem","volume":"6","author":"Ramage","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/600106","article-title":"Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces","volume":"200","author":"Swindell","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S173.e5","DOI":"10.1016\/j.ajic.2008.10.007","article-title":"Epidemiology of bloodstream infection associated with parenteral nutrition","volume":"36","author":"Opilla","year":"2008","journal-title":"Am. J. Infect. Control"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13693786.2010.530032","article-title":"Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex","volume":"49","author":"Melo","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1128\/AAC.46.11.3499-3505.2002","article-title":"Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection","volume":"46","author":"Lewis","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.01701-10","article-title":"Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion","volume":"55","author":"Uppuluri","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2006.09.004","article-title":"In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates","volume":"57","author":"Shuford","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","article-title":"The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: An in vitro interaction of antifungal and antibacterial agents","volume":"10","author":"Shi","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/AAC.47.11.3657-3659.2003","article-title":"Antifungal combinations against Candida albicans biofilms in vitro","volume":"47","author":"Bachmann","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jac\/dkp429","article-title":"In vitro activity of antifungal combinations against Candida albicans biofilms","volume":"65","author":"Tobudic","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.02541-12","article-title":"Speciespecific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: Characterization of less common bloodstream isolates","volume":"57","author":"Simitsopoulou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/AAC.02738-14","article-title":"Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms","volume":"58","author":"Guembe","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.01141-06","article-title":"Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals","volume":"51","author":"Choi","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","article-title":"In vitro activity of caspofungin against Candida albicans biofilms","volume":"46","author":"Bachmann","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ja.2013.83","article-title":"In vitro effectiveness of anidulafungin against Candida sp. biofilms","volume":"66","author":"Rosato","year":"2013","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.00211-08","article-title":"In vitro activity of anidulafungin against Candida albicans biofilms","volume":"52","author":"Jacobson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","first-page":"272","article-title":"In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms","volume":"24","author":"Valentin","year":"2007","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01569-10","article-title":"In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species","volume":"55","author":"Fiori","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/dkr429","article-title":"Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms","volume":"67","author":"Nweze","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1111\/j.1439-0507.2011.02036.x","article-title":"Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation","volume":"54","author":"Bernhardt","year":"2011","journal-title":"Mycoses"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/AAC.01724-08","article-title":"In vitro activity of micafungin against planktonic and sessile Candida albicans isolates","volume":"53","author":"Jacobson","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2009.07.001","article-title":"In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms","volume":"34","author":"Miceli","year":"2009","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1099\/jmm.0.032235-0","article-title":"In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms","volume":"60","author":"Ku","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/AAC.00316-09","article-title":"Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates","volume":"53","author":"Ferreira","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1130-1406(08)70030-5","article-title":"Activity of anidulafungin against Candida biofilms","volume":"25","author":"Peman","year":"2008","journal-title":"Rev. Iberoam Micol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dki269","article-title":"Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms","volume":"56","author":"Cocuaud","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.02290-12","article-title":"Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole","volume":"57","author":"Kaneko","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2006.07.024","article-title":"In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections","volume":"28","author":"Seidler","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jac\/dkr473","article-title":"Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?","volume":"67","author":"Toulet","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10156-011-0224-3","article-title":"In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species","volume":"17","author":"Oncu","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dkn160","article-title":"In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth","volume":"62","author":"Cateau","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2010.12.016","article-title":"Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone","volume":"37","author":"Cateau","year":"2011","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3346\/jkms.2010.25.12.1722","article-title":"In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms","volume":"25","author":"Ko","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11046-011-9448-0","article-title":"Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis","volume":"172","author":"Pires","year":"2011","journal-title":"Mycopathologia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13693786.2010.492482","article-title":"In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms","volume":"49","author":"Rukayadi","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/502577","article-title":"Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm","volume":"26","author":"Percival","year":"2005","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1128\/AAC.00263-12","article-title":"In vitro analyses of ethanol activity against Candida albicans biofilms","volume":"56","author":"Rane","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.01287-12","article-title":"Chelator-based catheter lock solutions in eradicating organisms in biofilm","volume":"57","author":"Raad","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.00154-06","article-title":"Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/AAC.00229-13","article-title":"Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms","volume":"57","author":"Rosenblatt","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijantimicag.2008.07.030","article-title":"Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms","volume":"33","author":"Mukherjee","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.48.5.1727-1732.2004","article-title":"Rabbit model of Candida albicans biofilm infection: Liposomal amphotericin B antifungal lock therapy","volume":"48","author":"Schinabeck","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/506452","article-title":"Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model","volume":"194","author":"Shuford","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/dkp242","article-title":"Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis","volume":"64","author":"Lazzell","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.02288-12","article-title":"Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model","volume":"57","author":"Kucharikova","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00697-10","article-title":"In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis","volume":"4","author":"Kucharikova","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_100","first-page":"256","article-title":"Infections of long intravenous lines: New developments and controversies","volume":"20","author":"Samore","year":"2000","journal-title":"Curr. Clin. Top. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: Analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1086\/653936","article-title":"Should the guidelines for management of central venous catheters in patients with candidemia be changed now?","volume":"51","author":"Brass","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1086\/657244","article-title":"Early removal of central venous catheters and outcomes from candidemia","volume":"51","author":"Koh","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e33705","DOI":"10.1371\/journal.pone.0033705","article-title":"Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital","volume":"7","author":"Tumbarello","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1469-0691.2007.01758.x","article-title":"Impact of early central venous catheter removal on outcome in patients with candidaemia","volume":"13","author":"Rodriguez","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QCO.0b013e32830634d8","article-title":"The role of chelators in preventing biofilm formation and catheter-related bloodstream infections","volume":"21","author":"Raad","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01351-12","article-title":"Antifungal lock therapy","volume":"57","author":"Walraven","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/jac\/dks376","article-title":"In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections","volume":"68","author":"Cobrado","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.05836-11","article-title":"Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi","volume":"56","author":"Raad","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/652764","article-title":"In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection","volume":"50","author":"Maki","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jinf.2006.03.002","article-title":"Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care","volume":"54","author":"Khare","year":"2007","journal-title":"J. Infect."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/651558","article-title":"Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model","volume":"201","author":"Martinez","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182784867","article-title":"Echinocandin and ethanol lock therapy treatment of fungal catheter infections","volume":"32","author":"Pieroni","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1469-0691.2002.00388.x","article-title":"The antibiotic-lock technique for therapy of \u201chighly needed\u201d infected catheters","volume":"8","author":"Carratala","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0148607188012002185","article-title":"Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients","volume":"12","author":"Messing","year":"1988","journal-title":"JPEN J. Parenter Enteral Nutr."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/clind\/24.4.743b","article-title":"Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home","volume":"24","author":"Benoit","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2307\/30141101","article-title":"Treatment of Hickman catheter sepsis using antibiotic lock technique","volume":"16","author":"Krzywda","year":"1995","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1111\/j.1439-0507.2010.01964.x","article-title":"Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy","volume":"54","author":"Ozdemir","year":"2011","journal-title":"Mycoses"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0002-9343(91)90518-3","article-title":"Malassezia furfur catheter infection cured with antibiotic lock therapy","volume":"90","author":"Arnow","year":"1991","journal-title":"Am. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00006454-199410000-00015","article-title":"Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients","volume":"13","author":"Johnson","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1086\/323554","article-title":"Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?","volume":"33","author":"Viale","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.inf.0000172929.23419.cb","article-title":"Broviac catheter-related candidemia","volume":"24","author":"Castagnola","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jinf.2004.08.034","article-title":"Candida glabrata fungemia cured by antibiotic-lock therapy: Case report and short review","volume":"51","author":"Boronat","year":"2005","journal-title":"J. Infect."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jac\/dkm262","article-title":"Antibiotic-lock therapy and erythromycin for treatment of catheter-related Candida parapsilosis and Staphylococcus aureus infections","volume":"60","author":"Wu","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/INF.0b013e318170b68b","article-title":"Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy","volume":"27","author":"Buckler","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/INF.0b013e31822c84a4","article-title":"Ethanol locks therapy for resolution of fungal catheter infections","volume":"30","author":"Blackwood","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jac\/dkq446","article-title":"Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei","volume":"66","author":"Shorr","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10156-009-0689-5","article-title":"Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: Evaluation using the AKOTT algorithm","volume":"15","author":"Aikawa","year":"2009","journal-title":"J. Infect. Chemother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/14740338.2011.557062","article-title":"Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases","volume":"10","author":"Cornely","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/14767058.2011.604929","article-title":"The management of Candida infections in preterm neonates and the role of micafungin","volume":"24","author":"Manzoni","year":"2011","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial","volume":"27","author":"Berezin","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/08927014.2010.534552","article-title":"Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation","volume":"26","author":"Privett","year":"2010","journal-title":"Biofouling"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkn034","article-title":"Antimicrobial surface functionalization of plastic catheters by silver nanoparticles","volume":"61","author":"Roe","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/AAC.01622-05","article-title":"Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters","volume":"50","author":"Hanna","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-003-2093-4","article-title":"Evaluation of a triple-lumen central venous heparin-coated catheter vs. a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients","volume":"30","author":"Carrasco","year":"2004","journal-title":"Intensive Care Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/CCM.0b013e3181f265ba","article-title":"Anti-infective external coating of central venous catheters: A randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine\/silver sulfadiazine in preventing catheter colonization","volume":"38","author":"Walz","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/500280","article-title":"Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: The promise of a novel antiseptic-barrier cap","volume":"27","author":"Menyhay","year":"2006","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"S174.e1","DOI":"10.1016\/j.ajic.2008.10.006","article-title":"Preventing central venous catheter-associated bloodstream infections: Development of an antiseptic barrier cap for needleless connectors","volume":"36","author":"Menyhay","year":"2008","journal-title":"Am. J. Infect. Control."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.CCM.0000026327.58305.22","article-title":"Antiseptic chamber-containing hub reduces central venous catheter-related infection: A prospective, randomized study","volume":"31","author":"Leon","year":"2003","journal-title":"Crit. Care Med."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/4\/1\/1\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:11:43Z","timestamp":1760217103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/4\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,25]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["antibiotics4010001"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics4010001","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,25]]}}}